← Compound index
COMPOUND RECORD / GZS-411

GZS-411ГЗС-411

A synthetic dimeric dipeptide designed to mimic loop 1 of neurotrophin-4, a nerve-cell signaling protein. The reported experiments measured cellular responses.

CognitionRecovery
Source linked

What the studies found

Lab research · 2026

N-Isocaproyl-L-Arginylglycine Hexamethylenediamide, First Low-Molecular-Weight Mimetic of Neurotrophin-4: Design and Neuroprotective Activity.

GZS-411 activated TrkB and protected cultured cells against oxidative stress, glutamate toxicity and 6-hydroxydopamine. The study does not establish animal or human treatment effects.

Study notes · methods, sources and limitations

Participants or model Mouse HT-22 and human SH-SY5Y cell lines

Important limitations

  • Preclinical findings do not establish human benefit or safety. Abstract only. Full methods and independent replication remain unconfirmed.

Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · Indexed abstract

Original source or citation ↗

Study results and tables ↗
01 / OVERVIEW

About GZS-411

Names in this research collection

NT-4 · Neurotrophin-4 · N-isocaproyl-L-arginylglycine hexamethylenediamide

Research background

A 2026 experimental dimeric dipeptide designed from NT-4 loop 1. Its currently linked findings are cell-based.

Compound class
Experimental peptide
Research collection
Neuropeptide research · editorial grouping
Institutions in linked studies
See individual study records
Source review
Review dates and the material assessed are listed with each publication below.
02 / HOW TO READ THE RESEARCH

Understanding the evidence

Human research

No human treatment trial assessed for this family

Study methods

Member-specific studies; patents and archival leads identified separately

Independent replication

Independent replication not established by the records collected here

Source access

Primary abstracts, selected full texts, patents and explicit retrieval targets

Safety evidence

Cell and animal effects do not establish human safety; analogues may differ

Open a topic for the evidence assessment.

More findings, background and history
IDENTITY / MEMBER-SPECIFIC EVIDENCE

The research record

Grouping supports navigation. It does not imply equivalent composition, mechanisms, effectiveness or safety.

Research objects, findings and source boundaries
MemberIdentityWhat the source supports
GZS-411NT-4 loop 1 mimetic

TrkB activation and protection in HT-22 and SH-SY5Y injury assays.

N-Isocaproyl-L-Arginylglycine Hexamethylenediamide, First Low-Molecular-Weight Mimetic of Neurotrophin-4: Design and Neuroprotective Activity. ↗

Interpretation and open questions

Human-derived SH-SY5Y cells are not human participants. No human efficacy inference is made.

An additional GZS-4xx analogue library is not established by the located source.

Explore the Russian peptide research map ↗

What remains unclear

The available experimental studies leave human benefit and safety uncertain.

No human intervention report has been identified among the linked records; unclassified archival leads may remain. Several publications can describe the same participants.

Browse original study records ↗
03 / SOURCE RECORDS

Findings by study

Explore related research ↗

Lab research · 2026

N-Isocaproyl-L-Arginylglycine Hexamethylenediamide, First Low-Molecular-Weight Mimetic of Neurotrophin-4: Design and Neuroprotective Activity.

GZS-411 activated TrkB and protected cultured cells against oxidative stress, glutamate toxicity and 6-hydroxydopamine. The study does not establish animal or human treatment effects.

Study notes and original source
2026In vitroEnglish abstract

N-Isocaproyl-L-Arginylglycine Hexamethylenediamide, First Low-Molecular-Weight Mimetic of Neurotrophin-4: Design and Neuroprotective Activity.

Gudasheva TA, Sokolenko NI, Kolyasnikova KN, Antipova TA, Zainullina LF, Sergeeva MS, Dorofeev VL · Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections

GZS-411 activated TrkB and protected cultured cells against oxidative stress, glutamate toxicity and 6-hydroxydopamine. The study does not establish animal or human treatment effects.

Population / setting
Mouse HT-22 and human SH-SY5Y cell lines
Source reviewed
Primary publication metadata and indexed abstract checked via Europe PMC; full methodological review pending.
Study limitations
  • Preclinical findings do not establish human benefit or safety.
  • Abstract only. Full methods and independent replication remain unconfirmed.

Reviewed 2026-10-05.

Read the source ↗

Research collection curated by @PepMariner · editorial standards. Send a source correction ↗

Browse bibliography & PDFs ↗